ArticleOrthopaedic journal of sports medicine2025
Association between Increased Age at Anterior Cruciate Ligament Reconstruction and Metabolic Syndrome.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic syndrome (MetSy) is a global pandemic characterized by a cluster of interrelated abnormalities and risk factors. The prevalence of MetSy increases with advancing age. It is unknown whether increased age at the time of anterior cruciate ligament reconstruction (ACLR) is associated with an increased prevalence of MetSy. Purpose: To identify the association of age at ACLR with MetSy. Study Design: Cohort study; Level of evidence, 3. Methods: Patients aged ≥18 years who underwent ACLR, with available blood pressure, blood lipids, hemoglobin A1c (HbA1c), and basic descriptive data, were included. All data were extracted from the medical records at a single academic institution. MetSy was defined as meeting any 3 of the following 5 criteria: (1) body mass index (BMI) ≥30 kg/m Results: The final analysis consisted of 493 patients (age, 18-29 years [n = 139]; 30-39 years [n = 158]; 40-49 years [n = 135]; and ≥50 years [n = 61]). Based on the criteria, 190 (38.5%) patients who underwent ACLR displayed MetSy. The prevalence of MetSy was not significantly different between age groups ( Conclusion: Increased age at ACLR was not associated with MetSy but may be associated with an elevated HbA1c and estimated fasting glucose.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.